Tisdag 14 Oktober | 16:59:34 Europe / Stockholm

Kalender

Est. tid*
2026-02-26 08:00 Bokslutskommuniké 2025
2025-11-13 07:00 Kvartalsrapport 2025-Q3
2025-08-27 - Kvartalsrapport 2025-Q2
2025-08-14 - Extra Bolagsstämma 2025
2025-07-04 - Split IDEX 100:1
2025-05-22 - X-dag ordinarie utdelning IDEX 0.00 NOK
2025-05-21 - Årsstämma
2025-05-21 - Kvartalsrapport 2025-Q1
2025-02-27 - Bokslutskommuniké 2024
2024-11-07 - Kvartalsrapport 2024-Q3
2024-10-09 - Extra Bolagsstämma 2024
2024-09-23 - Extra Bolagsstämma 2024
2024-08-15 - Kvartalsrapport 2024-Q2
2024-05-21 - X-dag ordinarie utdelning IDEX 0.00 NOK
2024-05-16 - Årsstämma
2024-05-16 - Kvartalsrapport 2024-Q1
2024-02-29 - Bokslutskommuniké 2023
2024-01-09 - Split IDEX 5:1
2023-12-21 - Extra Bolagsstämma 2023
2023-11-09 - Kvartalsrapport 2023-Q3
2023-08-10 - Kvartalsrapport 2023-Q2
2023-06-16 - Extra Bolagsstämma
2023-05-23 - Årsstämma
2023-05-23 - Kvartalsrapport 2023-Q1
2023-05-12 - X-dag ordinarie utdelning IDEX 0.00 NOK
2023-02-22 - Bokslutskommuniké 2022
2022-12-09 - Extra Bolagsstämma 2022
2022-11-10 - Kvartalsrapport 2022-Q3
2022-08-11 - Kvartalsrapport 2022-Q2
2022-05-13 - X-dag ordinarie utdelning IDEX 0.00 NOK
2022-05-12 - Årsstämma
2022-05-12 - Kvartalsrapport 2022-Q1
2022-02-24 - Bokslutskommuniké 2021
2021-11-04 - Kvartalsrapport 2021-Q3
2021-08-12 - Kvartalsrapport 2021-Q2
2021-05-12 - Årsstämma
2021-05-12 - Kvartalsrapport 2021-Q1
2021-05-03 - X-dag ordinarie utdelning IDEX 0.00 NOK
2021-02-25 - Bokslutskommuniké 2020
2020-12-15 - Extra Bolagsstämma 2020
2020-11-05 - Kvartalsrapport 2020-Q3
2020-08-13 - Kvartalsrapport 2020-Q2
2020-05-15 - X-dag ordinarie utdelning IDEX 0.00 NOK
2020-05-14 - Årsstämma
2020-05-14 - Kvartalsrapport 2020-Q1
2020-02-27 - Bokslutskommuniké 2019
2019-12-12 - Extra Bolagsstämma 2019
2019-11-13 - Kvartalsrapport 2019-Q3
2019-08-15 - Kvartalsrapport 2019-Q2
2019-05-10 - X-dag ordinarie utdelning IDEX 0.00 NOK
2019-05-09 - Årsstämma
2019-05-09 - Kvartalsrapport 2019-Q1
2019-02-27 - Bokslutskommuniké 2018
2018-11-08 - Kvartalsrapport 2018-Q3
2018-08-16 - Kvartalsrapport 2018-Q2
2018-05-11 - X-dag ordinarie utdelning IDEX 0.00 NOK
2018-05-09 - Årsstämma
2018-05-09 - Kvartalsrapport 2018-Q1
2018-02-22 - Bokslutskommuniké 2017
2017-11-02 - Kvartalsrapport 2017-Q3
2017-08-10 - Kvartalsrapport 2017-Q2
2017-05-15 - X-dag ordinarie utdelning IDEX 0.00 NOK
2017-05-12 - Årsstämma
2017-05-12 - Kvartalsrapport 2017-Q1
2017-02-23 - Bokslutskommuniké 2016
2016-11-10 - Kvartalsrapport 2016-Q3
2016-08-11 - Kvartalsrapport 2016-Q2
2016-05-12 - X-dag ordinarie utdelning IDEX 0.00 NOK
2016-05-11 - Årsstämma
2016-05-11 - Kvartalsrapport 2016-Q1
2016-02-26 - Bokslutskommuniké 2015
2015-11-11 - Kvartalsrapport 2015-Q3
2015-08-12 - Kvartalsrapport 2015-Q2
2015-05-13 - X-dag ordinarie utdelning IDEX 0.00 NOK
2015-05-12 - Årsstämma
2015-05-12 - Kvartalsrapport 2015-Q1
2015-04-29 - Extra Bolagsstämma 2015
2015-02-24 - Bokslutskommuniké 2014
2014-11-12 - Kvartalsrapport 2014-Q3
2014-08-13 - Kvartalsrapport 2014-Q2
2014-05-08 - X-dag ordinarie utdelning IDEX 0.00 NOK
2014-05-07 - Årsstämma
2014-05-07 - Kvartalsrapport 2014-Q1
2014-04-10 - X-dag ordinarie utdelning IDEX 0.00 NOK
2014-02-21 - Bokslutskommuniké 2013
2014-01-29 - Extra Bolagsstämma 2014
2013-11-13 - Kvartalsrapport 2013-Q3
2013-08-14 - Kvartalsrapport 2013-Q2
2013-05-17 - X-dag ordinarie utdelning IDEX 0.00 NOK
2013-05-16 - Årsstämma
2013-05-16 - Kvartalsrapport 2013-Q1
2013-02-27 - Bokslutskommuniké 2012
2012-11-13 - Kvartalsrapport 2012-Q3
2012-08-16 - Kvartalsrapport 2012-Q2
2012-05-16 - X-dag ordinarie utdelning IDEX 0.00 NOK
2012-05-15 - Årsstämma
2012-05-15 - Kvartalsrapport 2012-Q1
2012-02-28 - Bokslutskommuniké 2011
2011-11-15 - Kvartalsrapport 2011-Q3
2011-08-23 - Kvartalsrapport 2011-Q2
2011-05-20 - X-dag ordinarie utdelning IDEX 0.00 NOK
2011-05-19 - Årsstämma
2011-05-18 - Kvartalsrapport 2011-Q1
2011-02-28 - Bokslutskommuniké 2010

Beskrivning

LandNorge
ListaOslo Bors
SektorInformationsteknik
IndustriElektronisk utrustning
IDEX Biometrics är ett norskt teknikbolag inriktat mot att utveckla och kommersialisera produkter inom avancerad sensorteknik som används vid fingeravtrycksläsning. Bolagets produkter används inom en mängd biometriska aktiverade enheter på marknader som mobiltelefoner, smartkort, och inom segmentet IoT (Internet of Things). Bolaget grundades 1996 och har sitt huvudkontor i Oslo.
2025-07-21 07:30:00
NOT  FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN  WHOLE OR IN PART, DIRECTLY OR
INDIRECTLY,  IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN OR THE UNITED STATES
OR  ANY OTHER  JURISDICTION IN  WHICH THE  RELEASE, PUBLICATION  OR DISTRIBUTION
WOULD  BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE
SECURITIES DESCRIBED HEREIN.

Oslo, Norway, 21 July 2025

IDEX  Biometrics ASA ("IDEX" or the  "Company") has engaged Arctic Securities AS
(the  "Manager") to advise on and effect a contemplated private placement in the
Company  of 9,090,909 new  shares in  the Company  (the "Offer  Shares") raising
gross  proceeds of  NOK 30 million  (the "Private  Placement"). The subscription
price per Offer Share (the "Offer Price") is NOK 3.30 per Offer Share.

Altea  AS, Pinchcliffe AS (closely associated company of the CEO and CFO, Anders
Storbråten), Anders Storbråten, Charles Street International Ltd. (Robert Keith)
and  K-Konsult AS (closely associated company of the chairperson of the board of
directors,  Morten  Opstad)  (the  "Underwriters")  have,  subject  to customary
conditions,  accepted  to  be  allocated  Offer  Shares that are not applied for
during  the Application  Period (as  defined herein)  for up  to NOK 30,000,000
pursuant to an underwriting agreement entered into with the Company (the "UWA").
An  underwriting  fee  equal  to  5% of  the  underwriting  commitment  by  each
Underwriter  will be payable by  the Company to each  of the Underwriters in the
form  of  a  total  of  454,542 new  shares  in  the  Company (the "Underwriting
Shares"), subject to the approval and issuance of the Underwriting Shares by the
EGM (as defined herein).

The  net  proceeds  from  the  Private  Placement  will  be  used  to  Company's
commercialization  efforts in line  with the new  business strategy announced in
March 2025 as well as for general corporate purposes.

The  application period for  the Private Placement  will commence today, 21 July
2025 at 09:00 CEST and is expected to close no later than 21 July 2025 at 16:30
CEST  (the "Application Period"). The Company, in consultation with the Manager,
reserves the right to at any time and in its sole discretion resolve to close or
extend the Application Period or to cancel the Private Placement in its entirety
without  further notice. If the Application Period is shortened or extended, any
other dates referred to herein may be amended accordingly.

The  final  number  of  Offer  Shares  will  be  determined  at  the  end of the
Application Period, and the final allocation will be made at the sole discretion
of  the Board after consulting with the Manager. The allocation will be based on
criteria  such as (but  not limited to) timeliness  of the application, relative
order size, sector knowledge, investment history, perceived investor quality and
investment  horizon. The Board may, at its sole discretion, reject and/or reduce
any  applications. There  is no  guarantee that  any applicant will be allocated
Offer  Shares. Notification of allotment and payment instructions is expected to
be  issued to the applicants on  or about 22 July 2025 through a notification to
be issued by the Manager.

The  Private Placement  will be  divided into  two tranches: Tranche 1 ("Tranche
1") will  consist of up to 4,731,594 Offer Shares,  which may be issues based on
the current outstanding authorization to issue new shares given to the Company's
board  of directors ("Board") by the  annual general meeting on 21 May 2025 (the
"Authorization") and Tranche 2 ("Tranche 2") will consist of the number of Offer
Shares  that, together with the Tranche 1 shares, is necessary in order to raise
gross  proceeds of NOK  30 million. The issuance  of Offer Shares  in Tranche 2
remains subject to approval by an extraordinary general meeting, scheduled to be
held  on or about 14 August 2025 (the "EGM"). Applicants will receive a pro rata
portion of shares from Tranche 1 and Tranche 2 based on their overall allocation
in  the  Private  Placement,  with  the  exception of the Underwriters which has
agreed  that the new shares it is allocated in the Private Placement will all be
allocated in Tranche 2.

Tranche  1 will be settled with existing  and unencumbered shares in the Company
that  are already  listed on  Oslo Børs,  pursuant to  a share lending agreement
entered  into between the Company, the  Manager and an existing shareholder (the
"Share Lending Agreement"). The Share Lending Agreement will be settled with new
shares  in  the  Company  to  be  resolved  issued  by the Board pursuant to the
Authorization.  Settlement of the Private Placement is expected to take place on
a delivery versus payment basis on or about 24 July 2025.

The  completion of Tranche 1 is  subject to (i) approval  by the Board under the
Authorization  and (ii)  the Share  Lending Agreement  and the UWAs remaining in
full  force and effect ("Tranche 1 Conditions").  The completion of Tranche 2 is
subject  to (i) completion of Tranche 1, (ii)  approval by the EGM and (iii) the
Share Lending Agreement and the UWA remaining in full force and effect ("Tranche
2 Conditions").  Both  the  Tranche  1 Conditions  and  the Tranche 2 Conditions
include  the share capital increase pertaining  to the issuance of the allocated
Offer  Shares under  such tranche  being validly  registered with  the Norwegian
Register  of Business Enterprises  and the allocated  Offer Shares being validly
issued  and registered in  the Norwegian Central  Securities Depository Euronext
Securities  Oslo  ("VPS"),  Completion  of  Tranche  1 is  not  conditional upon
completion  of Tranche  2, and acquisition  of shares  in Tranche  1 will remain
final  and  binding  and  cannot  be  revoked  or  terminated  by the respective
applicants  if  Tranche  2 is  not  completed.  The  Board reserves the right to
cancel,  and/or modify the terms  of the Private Placement,  at any time and for
any  reason prior to  delivery of the  Offer Shares in  Tranche 1, without or on
short  notice. The  Applicant acknowledges  that Tranche  1 and Tranche 2 of the
Private Placement will be cancelled if the relevant conditions for such tranches
(or  issuance) are not fulfilled, and may be  cancelled by the Board in its sole
discretion for any other reason whatsoever prior to delivery of the Offer Shares
in  Tranche 1. Neither the Manager nor the Company will be liable for any losses
if  the Private Placement  is cancelled or  modified, irrespective of the reason
for such cancellation or modification.

The  Private  Placement  will  be  directed  towards Norwegian and international
investors,  subject to applicable exemptions  from relevant registration, filing
and   prospectus   requirements,   and   subject  to  other  applicable  selling
restrictions.  The minimum application and allocation amount has been set to the
NOK  equivalent of EUR 100,000. The Company may however, at its sole discretion,
allocate  amounts below EUR 100,000 to the extent exemptions from the prospectus
requirements  in accordance with applicable regulations, including the Norwegian
Securities Trading Act and ancillary regulations, are available.

The  Board has  considered the  contemplated Private  Placement in  light of the
equal  treatment obligations under the Norwegian Securities Trading Act and Oslo
Børs' Circular no. 2/2014 and deems that the proposed Private Placement would be
in  compliance with these requirements. The Board holds the view that it will be
in  the common  interest of  the Company  and its  shareholders to  raise equity
through  a private placement, in  view of the current  market conditions and the
growth  opportunities currently  available to  the Company.  A private placement
enables  the Company to  raise capital in  an efficient manner,  and the Private
Placement  is structured  to ensure  that a  market-based subscription  price is
achieved.  In order to limit the dilutive effect of the Private Placement and to
facilitate  equal treatment, the  Board will consider  carrying out a subsequent
offering  directed towards shareholders  who did not  participate in the Private
Placement (see details below).

The Subsequent Offering
Subject  to among  other things  (i) completion  of the  Private Placement, (ii)
relevant   corporate   resolutions  including  approval  by  the  Board  and  an
extraordinary  general  meeting,  (iii) the  prevailing  market  price of IDEX's
shares  being higher than the Offer  Price, and (iv) approval of a prospectus by
the  Norwegian Financial  Supervisory Authority,  IDEX will  consider whether to
carry out a subsequent offering (the "Subsequent Offering") of new shares in the
Company.  A  Subsequent  Offering  will,  if  made, be directed towards existing
shareholders in the Company as of 21 July 2025, as registered in IDEX's register
of shareholders with Euronext Securities Oslo, the central securities depositary
in Norway (Nw. Verdipapirsentralen) (the "VPS") two trading days thereafter, who
(i)  are not allocated Offer  Shares in the Private  Placement, and (ii) are not
resident in a jurisdiction where such offering would be unlawful or would (other
than Norway) require any prospectus, filing, registration or similar action (the
"Eligible  Shareholders"). The Eligible Shareholders  are expected to be granted
non-tradable  allocation rights.  If carried  out, the  subscription period in a
Subsequent  Offering is  expected to  commence shortly  after publication of the
Prospectus  (if relevant), and the subscription price in the Subsequent Offering
will  be the same as the Offer Price in the Private Placement. IDEX will issue a
separate  stock exchange notice with further  details on the Subsequent Offering
if and when finally resolved.

About IDEX Biometrics ASA
IDEX  Biometrics ASA  (OSE: IDEX)  is a  global technology leader in fingerprint
biometrics,  offering authentication solutions  across payments, access control,
and  digital identity. Our solutions bring  convenience, security, peace of mind
and  seamless user experiences  to the world.  Built on patented and proprietary
sensor  technologies, integrated  circuit designs,  and software,  our biometric
solutions    target   card-based   applications   for   payments   and   digital
authentication.   As   an   industry-enabler   we   partner  with  leading  card
manufacturers and technology companies to bring our solutions to market.

This  information  is  considered  to  be  inside information pursuant to the EU
Market  Abuse Regulation  (MAR) and  is subject  to the  disclosure requirements
pursuant to MAR article 17 and section 5 -12 of the Norwegian Securities Trading
Act.  This stock exchange  release was published  by Kjell-Arne Besseberg, Chief
Operating Officer, on 21 July 2025 at 07.30 CEST.

Important information:
This  announcement is not and  does not form a  part of any offer  to sell, or a
solicitation  of  an  offer  to  purchase,  any  securities  of the Company. The
distribution of this announcement and other information may be restricted by law
in certain jurisdictions. Copies of this announcement are not being made and may
not  be distributed  or sent  into any  jurisdiction in  which such distribution
would  be unlawful or would require registration or other measures. Persons into
whose  possession this  announcement or  such other  information should come are
required to inform themselves about and to observe any such restrictions.

The  securities referred to in  this announcement have not  been and will not be
registered  under the U.S.  Securities Act of  1933, as amended (the "Securities
Act"),  and accordingly may not  be offered or sold  in the United States absent
registration  or an applicable  exemption from the  registration requirements of
the Securities Act and in accordance with applicable U.S. state securities laws.
The  Company  does  not  intend  to  register  any  part  of the offering or its
securities in the United States or to conduct a public offering of securities in
the  United States. Any sale in the United States of the securities mentioned in
this  announcement will  be made  solely to  "qualified institutional buyers" as
defined in Rule 144A under the Securities Act.

In  any EEA Member  State, this communication  is only addressed  to and is only
directed  at qualified investors in that Member  State within the meaning of the
EU  Prospectus Regulation,  i.e., only  to investors  who can  receive the offer
without  an approved  prospectus in  such EEA  Member State.  The expression "EU
Prospectus  Regulation" means Regulation 2017/1129 as  amended together with any
applicable implementing measures in any Member State.

This  communication is only being distributed to and is only directed at persons
in  the  United  Kingdom  that  are  (i) investment professionals falling within
Article   19(5) of  the  Financial  Services  and  Markets  Act  2000 (Financial
Promotion) Order 2005, as amended (the "Order") or (ii) high net worth entities,
and  other  persons  to  whom  this  announcement  may lawfully be communicated,
falling  within Article 49(2)(a) to (d) of  the Order (all such persons together
being  referred to as "relevant persons").  This communication must not be acted
on  or relied  on by  persons who  are not  relevant persons.  Any investment or
investment  activity to which  this communication relates  is available only for
relevant  persons and  will be  engaged in  only with  relevant persons. Persons
distributing  this communication must satisfy themselves that it is lawful to do
so.

Matters   discussed   in   this   announcement  may  constitute  forward-looking
statements.  Forward-looking statements  are statements  that are not historical
facts  and may be identified by words such as "believe", "expect", "anticipate",
"strategy",  "intends",  "estimate",  "will",  "may",  "continue",  "should" and
similar  expressions. The forward-looking  statements in this  release are based
upon  various  assumptions,  many  of  which  are  based,  in turn, upon further
assumptions.   Although   the  Company  believes  that  these  assumptions  were
reasonable  when made, these  assumptions are inherently  subject to significant
known  and  unknown  risks,  uncertainties,  contingencies  and  other important
factors which are difficult or impossible to predict and are beyond its control.

Actual events may differ significantly from any anticipated development due to a
number  of factors, including  without limitation, changes  in investment levels
and  need for the Company's services, changes in the general economic, political
and market conditions in the markets in which the Company operate, the Company's
ability  to attract,  retain and  motivate qualified  personnel, changes  in the
Company's   ability  to  engage  in  commercially  acceptable  acquisitions  and
strategic  investments, and  changes in  laws and  regulation and  the potential
impact   of   legal   proceedings   and   actions.  Such  risks,  uncertainties,
contingencies  and other important  factors could cause  actual events to differ
materially  from the expectations  expressed or implied  in this release by such
forward-looking statements. The Company does not provide any guarantees that the
assumptions  underlying the forward-looking statements  in this announcement are
free  from errors nor does it accept  any responsibility for the future accuracy
of  the opinions expressed in  this announcement or any  obligation to update or
revise  the statements  in this  announcement to  reflect subsequent events. You
should  not  place  undue  reliance  on  the  forward-looking statements in this
document.

The  information,  opinions  and  forward-looking  statements  contained in this
announcement  speak  only  as  at  its  date,  and are subject to change without
notice.  The  Company  does  not  undertake  any  obligation  to review, update,
confirm,  or to release publicly any revisions to any forward-looking statements
to  reflect events  that occur  or circumstances  that arise  in relation to the
content of this announcement.

Neither  the Manager nor any  of their affiliates make  any representation as to
the  accuracy or completeness of this announcement  and none of them accepts any
responsibility  for the contents of this announcement or any matters referred to
herein.

This  announcement is for information purposes only and is not to be relied upon
in  substitution for the exercise of independent judgment. It is not intended as
investment  advice and under no circumstances is  it to be used or considered as
an  offer to  sell, or  a solicitation  of an  offer to  buy any securities or a
recommendation to buy or sell any securities in the Company. Neither the Manager
nor  any of their affiliates  accept any liability arising  from the use of this
announcement.